Form 8-K - Current report:
SEC Accession No. 0001683168-24-008640
Filing Date
2024-12-11
Accepted
2024-12-11 12:24:58
Documents
58
Period of Report
2024-12-11
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT cns_8k.htm   iXBRL 8-K 28016
2 PRESENTATION DATED DECEMBER 11, 2024 cns_ex9901.htm EX-99.1 45467
6 GRAPHIC image_001.jpg GRAPHIC 62014
7 GRAPHIC image_002.jpg GRAPHIC 157258
8 GRAPHIC image_003.jpg GRAPHIC 61153
9 GRAPHIC image_004.jpg GRAPHIC 117835
10 GRAPHIC image_005.jpg GRAPHIC 136823
11 GRAPHIC image_006.jpg GRAPHIC 106700
12 GRAPHIC image_007.jpg GRAPHIC 88945
13 GRAPHIC image_008.jpg GRAPHIC 77615
14 GRAPHIC image_009.jpg GRAPHIC 98614
15 GRAPHIC image_010.jpg GRAPHIC 64170
16 GRAPHIC image_011.jpg GRAPHIC 89376
17 GRAPHIC image_012.jpg GRAPHIC 97080
18 GRAPHIC image_013.jpg GRAPHIC 99686
19 GRAPHIC image_014.jpg GRAPHIC 69808
20 GRAPHIC image_015.jpg GRAPHIC 76476
21 GRAPHIC image_016.jpg GRAPHIC 91248
22 GRAPHIC image_017.jpg GRAPHIC 120455
23 GRAPHIC image_018.jpg GRAPHIC 120192
24 GRAPHIC image_019.jpg GRAPHIC 102915
25 GRAPHIC image_020.jpg GRAPHIC 85992
26 GRAPHIC image_021.jpg GRAPHIC 81573
27 GRAPHIC image_022.jpg GRAPHIC 97901
28 GRAPHIC image_023.jpg GRAPHIC 134751
29 GRAPHIC image_024.jpg GRAPHIC 95914
30 GRAPHIC image_025.jpg GRAPHIC 85799
31 GRAPHIC image_026.jpg GRAPHIC 75156
32 GRAPHIC image_027.jpg GRAPHIC 92924
33 GRAPHIC image_028.jpg GRAPHIC 85255
34 GRAPHIC image_029.jpg GRAPHIC 99669
35 GRAPHIC image_030.jpg GRAPHIC 61772
36 GRAPHIC image_031.jpg GRAPHIC 95707
37 GRAPHIC image_032.jpg GRAPHIC 89297
38 GRAPHIC image_033.jpg GRAPHIC 88675
39 GRAPHIC image_034.jpg GRAPHIC 127201
40 GRAPHIC image_035.jpg GRAPHIC 66364
41 GRAPHIC image_036.jpg GRAPHIC 110749
42 GRAPHIC image_037.jpg GRAPHIC 80526
43 GRAPHIC image_038.jpg GRAPHIC 98205
44 GRAPHIC image_039.jpg GRAPHIC 103444
45 GRAPHIC image_040.jpg GRAPHIC 85810
46 GRAPHIC image_041.jpg GRAPHIC 87915
47 GRAPHIC image_042.jpg GRAPHIC 51061
48 GRAPHIC image_043.jpg GRAPHIC 69621
49 GRAPHIC image_044.jpg GRAPHIC 57216
  Complete submission text file 0001683168-24-008640.txt   5842038

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE cnsp-20241211.xsd EX-101.SCH 3018
4 XBRL LABEL FILE cnsp-20241211_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE cnsp-20241211_pre.xml EX-101.PRE 24167
60 EXTRACTED XBRL INSTANCE DOCUMENT cns_8k_htm.xml XML 3802
Mailing Address 2100 WEST LOOP SOUTH SUITE 900 HOUSTON TX 77027
Business Address 2100 WEST LOOP SOUTH SUITE 900 HOUSTON TX 77027 1-800-946-9185
CNS Pharmaceuticals, Inc. (Filer) CIK: 0001729427 (see all company filings)

EIN.: 822318545 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39126 | Film No.: 241540811
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)